Skip to main content
. 2024 Feb 6;16(4):680. doi: 10.3390/cancers16040680
ABC transporters ATP-binding cassette transporters
ATM Ataxia Telangiectasia Mutated
BBB Blood–brain barrier
BCL-XL B-cell lymphoma-extra large
CAF Cancer-associated fibroblast
CAR-T Chimeric antigen receptor T-cell therapy
CAT Catalase
CDH2 Cadherin 2
cGAS Cyclic GMP-AMP synthase
Chk2 Checkpoint kinase 2
CPT Camptothecin
CRPC Castration-resistant prostate cancer
CSC Cancer stem cell
DOX Doxorubicin
DSB Double-strand break
dsDNA Double-stranded DNA
ECM Extracellular matrix
EV Extracellular Vesicles
GSH Glutathione
HDAC Histone deacetylase
HGF Hepatocyte growth factor
HR Homologous recombination
ICIT Immune checkpoint inhibitor therapies
MCH-I Major histocompatibility class I
MDR1 Multi-Drug Resistance Protein 1
miRNA microRNA
MMDX Nemorubicin
MXT Mitoxantrone
NADPH Nicotinamide adenine dinucleotide phosphate
NGS Next-generation sequencing
NHEJ Non-homologous end joining
PARP Poly(ADP-ribose) polymerase
PD-1/PD-L1 [PD-(L)1] Programmed cell death protein 1/Programmed death-ligand 1
PEG Polyethylene glycol
ROS Reactive oxygen species
RPA Replication Protein A
SNP Single nucleotide polymorphism
SOD Superoxide dismutase
ssDNA Single-stranded DNA
TGF Tumor growth factor
TGF-β Transforming growth factor beta
TME Tumor microenvironment
TNBC Triple-negative breast cancer
TOP1cc Topoisomerase I cleavage complex
TOP3α Topoisomerase III alpha
TOP3β Topoisomerase III beta
TOPI DNA topoisomerase I
TOPII DNA topoisomerase II
TOPmt Mitochondrial DNA topoisomerase
VP-16 Etoposide
ZEB1 Zinc finger E-box-binding homeobox 1